Hormonal Acne Supplements for PCOS/PMOS: What Actually Has Evidence?

I spent much of my 20s dealing with hormonal acne. This article used to give you five PCOS supplements to stack. The evidence does not support that.

I know how quickly a supplement list can become a shopping list. Here is the distinction I wish every list made: a study that changes insulin, testosterone, inflammation, or liver fat is not automatically a study that clears acne. When I held each ingredient to the outcome you can see on your face, the “top five” fell apart.

There are a few preliminary signals. There is no well-replicated oral supplement treatment for PCOS/PMOS acne, no proven five-product stack, and no study showing that a 40:1 inositol blend, zinc, omega-3, vitamin D, and spearmint should be taken together.

The PCOS/PMOS acne supplement evidence at a glance

A 2025 review identified seven PCOS nutraceutical studies that reported acne outcomes. I used it as a lead list, not a verdict. The review said it included randomized trials, but its final set contained an uncontrolled study and a partially randomized comparison. The underlying studies also used different acne measures, combination treatments, proprietary products, and short follow-up periods.

This is what remains when the direct acne result is separated from the surrounding mechanism:

That table is less satisfying than a numbered list. It is also much more useful if you are about to spend money or delay treatment.

What I would do with this evidence

My answer is not to replace the old five-product stack with a different stack. If acne is the problem you need to solve, use treatments with direct acne evidence. Consider a supplement only when you have a separate reason for it, such as correcting a documented deficiency or pursuing another PCOS/PMOS outcome, and test one decision at a time.

I would not buy five products at once. That makes adverse effects, interactions, cost, and any eventual skin change harder to interpret. I would not use a quiz to diagnose an insulin, adrenal, or inflammatory “type,” and I would not wait a mandatory 90 days before seeking effective acne care.

If you are considering one supplement, ask four plain questions:

1. Did a human study measure acne, or only a hormone or metabolic marker? 2. Was the ingredient tested alone, against a real comparator, in people like me? 3. Does my label reproduce the studied preparation and amount without pushing total intake into a safety problem? 4. What treatment am I delaying, and what will I do if the acne scars or worsens?

If acne is the decision, do not detour into “androgen blocking” instead of treating the acne. If your real decision is facial hair, scalp hair, cycles, fertility, or a laboratory result, our outcome-by-outcome guide to reducing androgens in women separates those questions.

Does inositol help with PCOS acne?

Possibly, but the direct evidence is mixed and does not establish the protocol usually sold online.

In one unblinded trial, 72 women were randomized to metformin alone or metformin plus myo-inositol and D-chiro-inositol for six months. The combination group had a better mean acne score at the end (Bahadur et al. 2021). This was not an inositol-versus-placebo trial. Both groups received metformin, and the inositol combination was about 3.7:1, not 40:1.

A later randomized study in 53 women also compared metformin alone with metformin plus an inositol combination. Its between-group acne result was not significant: 4.90 versus 4.81, P=.068 (Nazirudeen et al. 2023).

Those are not the only direct reports. A 137-woman myo-inositol-versus-D-chiro-inositol-versus-placebo study reported improved acne scores in both inositol groups, but did not provide the acne subgroup size, group values, or between-group analysis needed to judge the effect (Formuso et al. 2015). A separate 100-woman inositol-versus-placebo paper reported improvement descriptively, but its design reporting is internally inconsistent and it performed no inferential between-group acne analysis (Pezza and Carlomagno 2017).

A 2026 uncontrolled study gave myo-inositol and D-chiro-inositol to 45 adults, only 15 of whom had PCOS, and reported pooled clinical improvement without a PCOS-specific result or control group (Vaccaro et al. 2026). These reports add signals, not confirmation. They are not evidence that inositol is the foundational acne supplement, that 40:1 is superior for skin, or that everyone should judge it after exactly 90 days.

The broader comparative result is no stronger. A 2025 meta-analysis pooled four metformin add-on trials involving 277 women in its acne analysis and found no significant between-group difference, with substantial variation among the results (Kelly et al. 2025). A separate 50-woman trial comparing myo-inositol with metformin found no significant acne change in either group (Fruzzetti et al. 2017). An uncontrolled 50-woman study reported less acne after six months, but without a comparison group it cannot show what caused the change (Zacchè et al. 2009).

What about zinc, omega-3, and vitamin D?

These ingredients are often grouped together even though their evidence problems are different.

Zinc: Older general-acne trials have used different zinc salts and amounts with mixed results. The small PCOS trial is more directly relevant here, and its acne result was null. It reported 50 mg of elemental zinc a day, above the adult upper intake level, while both groups also received metformin. The paper's outcome registration and metformin descriptions conflict, and it carries a publisher investigation notice. Our zinc for PCOS evidence review explains why I would not turn that exposure into a dose.

Omega-3: A small 10-week study in 45 people with acne reported fewer inflammatory lesions with 1,000 mg EPA plus 1,000 mg DHA a day (Jung et al. 2014). Fifteen people received omega-3. That is an interesting general-acne signal, not replicated evidence for women with PCOS. The PCOS omega-3 studies cited in the old article measured testosterone and liver fat, not acne.

Vitamin D: One small trial found fewer inflammatory lesions after eight weeks in people with acne who were markedly vitamin-D deficient, but not fewer total or non-inflammatory lesions (Lim et al. 2016). A later trial found no week-12 lesion advantage when high-dose vitamin D was added to benzoyl peroxide, and it excluded PCOS (Ruikchuchit et al. 2024). Two PCOS trials were also null for acne: an 80-woman comparison of metformin, metformin plus calcium and vitamin D, calcium and vitamin D, and placebo found no group difference (Ghasemi Tehrani et al. 2014); a 39-woman trial of alfacalcidiol, metformin, or both found no significant acne improvement in any group (Dravecká et al. 2016). Alfacalcidiol is an active vitamin-D analogue, not an ordinary D3 supplement. Correcting a deficiency and treating PCOS acne are not the same decision.

I would not rank these three from “best” to “worst.” Zinc has more general acne history but a null and compromised PCOS result. Omega-3 has one tiny direct trial. Vitamin D's most encouraging signal is deficiency-bound. Each asks a different question.

Why I am not promoting berberine, selenium, or chromium instead

The apparently positive studies do not rescue the top-five format.

The larger berberine study randomized 130 women, but it was open-label and analyzed 106 completers. The treatment was a branded phytosome containing berberine extract, sunflower lecithin, pea protein, and grape-seed extract; the control group received no supplement. Product companies donated the material, and several authors disclosed commercial relationships. Twelve of 51 treated completers and five of 55 controls were classified as improved, while hormone and metabolic results did not significantly differ between groups (Di Pierro et al. 2023). That is a signal for an independent trial of the same preparation, not proof that a generic berberine capsule treats acne.

The Razavi et al. 2016 selenium paper reported the cleanest-looking number: improvement in 46.9% of the supplement group versus 12.5% with placebo. It is also under a formal Expression of Concern. The journal says serious concerns were raised about the integrity of the study's methods, results, and analysis, and that the authors' responses were unsatisfactory or inconclusive (Razavi et al. 2016 concern record). I am not going to put a troubled result at the top of a shopping list.

The chromium paper reported improvement in 20% of the supplement group versus 3.3% with placebo (Jamilian et al. 2016). Its acne measure collapsed everything from no acne to severe face-and-body acne into four grades. More importantly, Springer added a notice in 2020 saying editors were investigating concerns about the integrity of the reported trial. It remains an investigation, not a retraction, but the paper cannot carry a consumer recommendation.

Spearmint and “androgen blockers” do not get an acne claim for free

Spearmint tea changed some testosterone measurements in two short studies of women with hirsutism. Neither study measured acne. Reishi, saw palmetto, and white peony are commonly promoted from laboratory mechanisms, traditional use, prostate research, or hair studies. We did not locate a human oral trial showing that any of them improves acne in women with PCOS.

This matters because “may affect 5-alpha reductase” sounds close to “will reduce hormonal acne” while skipping the entire clinical result. A plausible pathway is where a trial begins. It is not where a treatment claim ends.

Hormonal acne is still acne

Jawline breakouts and premenstrual flares can be clues, but they do not diagnose PCOS or prove that insulin or high testosterone is the cause in one person. In one 374-woman study, only 11.2% had acne confined to the mandibular area (Dréno et al. 2015). Acne was also an unreliable marker of biochemical androgen excess in a large PCOS clinic population (Schmidt et al. 2016).

The old article said no topical treatment could reach hormonal acne. That was false. The 2024 American Academy of Dermatology guideline strongly recommends benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline. It also conditionally recommends options including azelaic acid, combined oral contraceptives, and spironolactone, depending on the person and treatment context (Reynolds et al. 2024).

A supplement does not become more “root cause” because it is swallowed. And an effective topical does not become superficial because hormones may contribute to the acne.

Severe, painful, scarring, rapidly worsening, or treatment-resistant acne deserves assessment rather than a supplement-only waiting period. The same is true when acne arrives with rapid facial-hair growth, voice change, or another marked androgen-related change. Topical retinoids and spironolactone are not pregnancy options. If you are pregnant or trying to conceive, choose acne treatment with your obstetric clinician or dermatologist (AAD pregnancy guidance).

How we checked the evidence

On September 2, 2026, we searched PubMed and ClinicalTrials.gov for oral supplements with acne outcomes in confirmed PCOS, PCOS-like phenotypes, and general acne populations; uncontrolled and mixed-population reports were treated as signals rather than treatment evidence. We checked the underlying studies identified by the 2025 PCOS nutraceutical review, current acne and PCOS guidance, trial registrations where available, publisher notices, conflicts, comparators, preparations, and whether acne was actually measured.

The result is not that supplements can never help. It is that the current PCOS/PMOS evidence cannot honestly produce a universal top five, a fixed stack, or a product handoff. That is the answer I would have wanted while I was dealing with hormonal acne in my 20s.